Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
- Status
- RecruitingResults none
- Why it is watched
- non-weight indication: kidney
- Who it enrolls
- age 18 Years to no upper limit; excludes diabetes; no BMI minimum stated; conditions: Obesity; Chronic Kidney Disease
- Interventions
- Semaglutide; Virtual Weight Management Coaching
- Conditions
- Obesity; Chronic Kidney Disease
- Phase and size
- Phase 4 · 60 participants
- Dates
- Start 2024-09-26
Primary completion 2026-09-30 - Sponsor
- Western University, Canada (Other)
- Last checked
- Sep 13, 2026
01Endpoints
What the trial will measure
- Feasibility of Recruitment12 months
02Eligibility
Who can take part
Inclusion Criteria: * Adults aged 18 years or older * BMI; 35 kg/m\^2 * 10% risk of ESKD requiring renal replacement therapy over 2 years or receiving dialysis Exclusion Criteria: * Known contraindication to a GLP-1RA (pancreatitis, personal or family history of medullary thyroid cancer, hypersensitivity) * Type 1 diabetes * No access to semaglutide via drug coverage * Pregnant, breastfeeding or planning to become pregnant * Currently in a GLP-1RA or GLP-1RA/GIP study or planning to be in one
03Change log
Registry changes
No changes recorded since the trial was added.